Repaglinide 1 mg is a notable medication that has attracted attention in the medical field for its effectiveness in controlling blood glucose levels among people with type 2 diabetes. It belongs to the class of medications known as antidiabetics. It belongs to the class of drugs known as meglitinides, which work by stimulating the pancreas to produce more insulin. This oral medication has the potential to provide significant benefits to patients struggling to control their blood sugar levels.
One of the main advantages of Repaglinide 1 mg is its rapid onset of action. Once ingested, this medication quickly reaches its maximum concentration in the blood within one hour, allowing for a rapid reduction in blood glucose levels. Compared to other oral antidiabetics, such as sulfonylureas, Repaglinide has a shorter half-life of approximately one hour. This rapid elimination from the body reduces the risk of prolonged hypoglycemia, which can be a concern for diabetics.
Important information:
- Repaglinide 1 mg should be taken orally before meals, usually 15 minutes before meal time.
- Dosage adjustment may be necessary in people with significant hepatic impairment or renal dysfunction.
- Patients should closely monitor their blood glucose levels while taking Repaglinide to ensure optimal control.
To better understand the effects of Repaglinide 1 mg, it is essential to examine the clinical data. A study conducted in individuals with type 2 diabetes showed that Repaglinide effectively reduced postprandial plasma glucose levels, which refer to blood sugar levels after a meal. The study also revealed that this medication was well tolerated, with no serious adverse effects reported.
| Drug name | Dose | Class | Action mode |
|---|---|---|---|
| Repaglinide 1 mg | 1mg | Meglitinide | Stimulates insulin production in the pancreas |
